Telix Tax Provision from 2010 to 2024

TLX Stock   15.76  0.16  1.03%   
Telix Pharmaceuticals Tax Provision yearly trend continues to be fairly stable with very little volatility. Tax Provision is likely to outpace its year average in 2024. Tax Provision is the amount set aside by Telix Pharmaceuticals Limited to cover any estimated taxes for the current period. It reflects Telix Pharmaceuticals' expected tax liabilities. View All Fundamentals
 
Tax Provision  
First Reported
2010-12-31
Previous Quarter
-2.1 M
Current Value
-2 M
Quarterly Volatility
2.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 1.1 M, Depreciation And Amortization of 7.1 M or Interest Expense of 7.1 M, as well as many indicators such as Price To Sales Ratio of 0.41, Days Sales Outstanding of 45.23 or Average Payables of 1.8 M. Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Telix Pharmaceuticals Correlation against competitors.

Latest Telix Pharmaceuticals' Tax Provision Growth Pattern

Below is the plot of the Tax Provision of Telix Pharmaceuticals Limited over the last few years. It is the amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities. Telix Pharmaceuticals' Tax Provision historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Tax Provision10 Years Trend
Slightly volatile
   Tax Provision   
       Timeline  

Telix Tax Provision Regression Statistics

Arithmetic Mean(2,144,520)
Coefficient Of Variation(105.43)
Mean Deviation1,325,104
Median(3,048,000)
Standard Deviation2,261,046
Sample Variance5.1T
Range8.5M
R-Value0.48
Mean Square Error4.2T
R-Squared0.23
Significance0.07
Slope241,616
Total Sum of Squares71.6T

Telix Tax Provision History

2024-2 M
2023-2.1 M
20225.5 M
202145 K

About Telix Pharmaceuticals Financial Statements

Telix Pharmaceuticals investors use historical fundamental indicators, such as Telix Pharmaceuticals' Tax Provision, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Telix Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tax Provision-2.1 M-2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.